Assessing Thermo Fisher Scientific (TMO) Valuation After Recent Share Price Pullback

robot
Abstract generation in progress

Thermo Fisher Scientific (TMO) has seen its share price pull back by 18% in the last month, prompting investors to re-evaluate its valuation. Despite the recent decline, the company is considered “undervalued” with a fair value of $540.27 compared to its current price of $515.60. The article suggests TMO is well-positioned for future growth driven by R&D, emerging markets, and M&A, but also highlights risks like tightening R&D budgets or acquisition integration issues.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
0/400
No comments
  • Pin

Trade Crypto Anywhere Anytime
qrCode
Scan to download Gate App
Community
English
  • 简体中文
  • English
  • Tiếng Việt
  • 繁體中文
  • Español
  • Русский
  • Français (Afrique)
  • Português (Portugal)
  • Bahasa Indonesia
  • 日本語
  • بالعربية
  • Українська
  • Português (Brasil)